Marketing an Aesthetic Clinic in Singapore: The Complete MOH-Compliant Playbook

The regulatory frame

Aesthetic clinic advertising in Singapore sits under the Healthcare Services Act and the Healthcare Services (Advertisement) Regulations administered by MOH, plus the SMC ethical guidelines. Between them they restrict before/after imagery, testimonials about outcomes, price promotions and superlative claims — the staples of unregulated beauty marketing. Requirements are described here in practical terms — always confirm specifics with MOH or your own adviser.

MOH Advertising Guidelines: The Complete List

The scannable version of what governs aesthetic clinic advertising in Singapore, with the detail behind each point in the sections that follow:

• No before-and-after imagery. Visual outcome comparisons are restricted regardless of consent — this is stricter than Malaysia's consent-based approach to the same imagery.
• No outcome testimonials. Patient accounts of results are not permitted in advertising; service-experience testimonials (how the visit felt, how staff treated them) sit in a narrower, more cautiously handled category.
• No price promotions on treatments. Discount-driven, time-limited pricing on medical aesthetic procedures is treated as inducement.
• No guarantees or superlatives. "Best," "guaranteed," "permanent" and similar claims are not defensible advertising language.
• No self-diagnosis prompts. Advertising cannot lead a reader to self-diagnose a condition and self-select a treatment without a consultation.
• Consultation-first framing required. The compliant structure positions every treatment decision as something assessed in consultation, not decided from an ad.
• DNC Registry compliance for follow-up. Once a lead is followed up by call or SMS, Singapore's Do Not Call rules apply on top of PDPA.

What's restricted (and the compliant move)

The pattern across all four restrictions is the same: Singapore's rules push advertising away from "here is the result, want it too" and toward "here is the process, come find out if it suits you." That is a harder brief to write well than a before/after post, but it converts a more qualified patient — someone who books because they trust the practice, not because they saw a result and want it copied onto themselves regardless of suitability.

How Singapore's rules compare to Malaysia's KKM rules

Clinics operating on both sides of the causeway need to hold two rulebooks in mind, and the differences are specific enough to catch out a campaign built for one market and copied to the other. Both Malaysia's KKM/MDC framework (see our full KKM and MDC guide) and Singapore's MOH framework restrict guaranteed outcomes, superlative claims and comparative advertising against named competitors — that overlap is large and gives a starting template that mostly transfers. Where they diverge matters more: Malaysia's before-and-after restrictions are consent- and context-dependent, with some controlled use permitted; Singapore's are closer to an outright restriction regardless of consent. Malaysia has no national Do Not Call registry governing marketing follow-up; Singapore's DNC Registry makes follow-up timing and consent wording a compliance question, not just a courtesy. And testimonials sit in a narrower band in Singapore than the "medical endorsement" test Malaysia applies — Singapore is generally the more conservative jurisdiction of the two on nearly every axis, which is the safe assumption to default to when a rule's application to a specific piece of creative is ambiguous.

The practical consequence for a dual-market clinic: build creative to Singapore's stricter standard by default, and it will almost always clear Malaysia's rules too — building to Malaysia's standard first and trying to loosen it for Singapore is the direction that gets campaigns rejected or flagged.

The SGD economics

Singapore CPLs run higher than Malaysia and must be budgeted in SGD. For aesthetic clinics, expect Meta cost per lead around SGD 25–80 and cost per booked consultation around SGD 120–350, depending on treatment mix and qualification. Because acquisition costs more, the qualification flow and show-rate matter even more than in Malaysia — a no-show in SGD is an expensive no-show. For the cross-market comparison against Malaysian benchmarks, see our Singapore vs Malaysia ad costs breakdown, and for the full ranges across every channel, our MY & SG benchmarks resource.

The compliance restrictions above interact directly with these economics. A clinic that can't lead with before/after imagery or price promotions has to work harder in the first few seconds of a scroll to earn attention — which typically means the creative production bar for a compliant, high-converting Singapore aesthetic ad is higher than for an unregulated category, and budget for creative testing should be planned accordingly rather than treated as an afterthought.

The PDPA + DNC layer

Singapore adds a compliance layer Malaysia doesn't: the Do Not Call (DNC) Registry on top of PDPA (SG). The moment you follow up a lead by call or SMS, DNC rules apply — so consent wording on the form and a DNC-aware follow-up process are part of the campaign, not optional. We cover this in depth in our DNC & PDPA (SG) post. This layer catches Malaysian clinics expanding into Singapore off guard most often, because Malaysia has no equivalent registry governing marketing follow-up calls — a lead-gen funnel that's perfectly compliant in KL can create real regulatory exposure the moment the same follow-up sequence runs against a Singapore phone number.

In practice, DNC compliance means checking a lead's number against the registry before any call or SMS follow-up, obtaining explicit consent for marketing contact at the point of enquiry (not assuming consent because someone filled a form), and keeping a record of that consent in case it's ever queried. WhatsApp sits in a different category from calls and SMS under current guidance, which is one reason WhatsApp-first follow-up has become the default structure for Singapore lead funnels — it sidesteps the DNC question entirely for the initial contact while still allowing a fast, personal response.

What actually converts within these rules

The clinics that perform best under Singapore's restrictions build their funnel around three assets the rules don't touch: practitioner credibility (qualifications, experience, specific expertise), process transparency (what a consultation actually involves, what questions get asked, how a treatment plan gets built), and facility quality (a clean, professional, trustworthy environment). None of these require a testimonial or a before/after photo to communicate, and all three are exactly what a patient comparing clinics for a decision this personal is actually looking for. The mistake we see most often in campaigns ported over from Malaysia is treating these three assets as filler content around a testimonial-led structure, rather than building the entire creative strategy around them from the start.

Treatment category also changes how tightly these restrictions bite. Injectables (Botox, fillers) sit at the most restricted end, because outcome variability and the medical risk profile draw the closest regulatory attention — education-led content explaining what the treatment involves and who is and isn't a suitable candidate is the safest and, in our experience, best-converting structure. Energy-based devices (laser, HIFU, RF) have slightly more room because the "before/after" instinct is weaker for these categories to begin with — process and technology explainer content performs well without needing to lean on restricted formats. Body contouring and injectables marketed as quick, dramatic transformations are where clinics most often drift toward non-compliant language, because the category's own marketing conventions elsewhere in the region lean heavily on exactly the imagery Singapore restricts.

Building a compliant creative pipeline, not a one-off review

The clinics that stay compliant without slowing their marketing down treat compliance as a step built into creative production, not a final check that happens after copy is written. That means briefing every creative concept against the restricted list before a single asset is produced, rather than writing freely and then editing out violations — the second approach produces watered-down versions of non-compliant ideas, which often still carry the spirit of the restriction even after the letter is fixed. A practical structure: maintain a short internal checklist mirroring the restricted list above, have every ad concept reviewed against it before production begins, and keep a record of what was approved and why, since MOH and platform reviewers can both query creative after the fact. This is slower for the first few campaigns and then becomes close to instant once the creative team internalises where the lines sit.

Platform review adds a second layer worth planning for separately from MOH compliance. Meta's own health and beauty advertising policies are stricter than general advertising policy and don't always map cleanly onto Singapore's specific restrictions — creative that would satisfy MOH can still be rejected by Meta's automated review for using medical terminology or implying a health claim, and the reverse is also true. Budgeting review time for both layers, rather than assuming MOH-compliant automatically means platform-approved, avoids the common experience of a fully compliant ad sitting in "in review" limbo for days before either passing or requiring a resubmission.

What we do differently in client accounts

We build Singapore aesthetic campaigns compliant-first — creative reviewed against the Advertisement Regulations and SMC guidance, SGD budgeting, WhatsApp conversion tracking, and a DNC-safe follow-up. It is exactly our Singapore aesthetic clinic programme, and the Malaysian counterpart logic is in our KKM-compliant ad copy post and the broader KKM and MDC advertising rules guide.

What to do about it

1. Don't port a Malaysian campaign as-is — re-check every ad against SG's Advertisement Regulations.
2. Replace before/after and testimonials with education, credibility and process transparency.
3. Budget in SGD (CPL ~SGD 25–80; cost per consult ~SGD 120–350) and protect show-rate.
4. Build DNC/PDPA-safe consent and follow-up into the funnel before the first lead arrives.